Reuters logo
2 months ago
BRIEF-PharmaMar, Eczacıbaşı sign licensing agreement for Aplidin in Turkey
May 25, 2017 / 2:49 PM / 2 months ago

BRIEF-PharmaMar, Eczacıbaşı sign licensing agreement for Aplidin in Turkey

1 Min Read

May 25 (Reuters) - Pharma Mar Sa:

* Announced licensing agreement with Eczacibaşi Group to commercialize marine-derived anticancer drug Aplidin (Plitidepsin) in Turkey

* Under terms, co will receive an upfront payment as well as development milestones related to health approval procedure of Aplidin

* Co will retain exclusive production rights and will supply finished product to Eczacibaşi for commercial use Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below